Research database
SVF Research Library
Search 52,792 real PubMed studies on SVF and adipose-derived stem cells — 57 matching records.
57 results — page 1 of 3
- Level DNarrative ReviewEurope PMC
Activation of Nrf2 with natural flavonoids and mesenchymal stromal/stem cells: mechanisms and therapeutic potential for inflammatory diseases
Narrative Review on Chronic Inflammation, Immune Modulation, published in Stem Cell Res Ther (2026) — summary generated from the PubMed abstract.
- 2026
Stem Cell Res Ther - Level AMeta-analysisEurope PMC
Therapeutic potential of mesenchymal stromal cells in COVID-19: a meta-analysis of clinical trials conducted since the pandemic onset
Meta-analysis with a reported sample of 1080 on Chronic Inflammation, published in Stem Cell Res Ther (2026) — summary generated from the PubMed abstract.
- 2026
- n = 1080
Stem Cell Res Ther - Level DAnimal StudyPubMed
Therapeutic potential of adipose-derived mesenchymal stem/stromal cells conditioned medium versus adipose-derived mesenchymal stem/stromal cells on treatment of polycystic ovary In-vivo.
Animal Study on Type 2 Diabetes, published in Tissue Cell (2026) — summary generated from the PubMed abstract.
- 2026
Tissue Cell - Level BClinical TrialPubMed
Combination of rapamycin and adipose-derived mesenchymal stromal cells enhances therapeutic potential for osteoarthritis.
Clinical Trial on Osteoarthritis, Chronic Inflammation, published in Stem Cell Res Ther (2025) — summary generated from the PubMed abstract.
- 2025
Stem Cell Res Ther7 citations - Level DAnimal StudyPubMed
Therapeutic potential of stromal vascular fraction in early diabetic nephrotoxicity: a histomorphometric and immunohistochemical analysis in a type 2 diabetes rat model.
Animal Study on Type 2 Diabetes, Chronic Kidney Disease, published in Folia Morphol (Warsz) (2025) — summary generated from the PubMed abstract.
- 2025
Folia Morphol (Warsz) - Level DAnimal StudyPubMed
The therapeutic potential of mesenchymal stromal cell secretome in treating spontaneous chronic corneal epithelial defects in dogs.
Animal Study, published in Res Vet Sci (2025) — summary generated from the PubMed abstract.
- 2025
Res Vet Sci - Level DAnimal StudyEurope PMC
Therapeutic potential of human mesenchymal stromal cell-derived mitochondria in a rat model of surgical digestive fistula
Animal Study on Chronic Wound, Autoimmune Research, published in Sci Rep (2025) — summary generated from the PubMed abstract.
- 2025
Sci Rep2 citations - Level ASystematic ReviewEurope PMC
A systematic review of preclinical studies on therapeutic potential of mesenchymal stem/stromal cells and their secretome in bacterial infections
Systematic Review, published in Stem Cell Res Ther (2025) — summary generated from the PubMed abstract.
- 2025
Stem Cell Res Ther3 citations - Level DNarrative ReviewPubMed
Advances in human amniotic placenta membrane-derived mesenchymal stromal cells (hAMSCs) for regenerative medicine: enhancing therapeutic potential with biomaterials and scaffolds.
Narrative Review on Immune Modulation, published in Front Bioeng Biotechnol (2025) — summary generated from the PubMed abstract.
- 2025
Front Bioeng Biotechnol - Level BClinical TrialPubMed
Exploring the Therapeutic Potential of Dedifferentiated Fat Progenitors (DFATs) in Comparison To the Adipose Derived Stem/Stromal Cells (ASCs).
Clinical Trial on Cartilage Damage, published in Stem Cell Rev Rep (2025) — summary generated from the PubMed abstract.
- 2025
Stem Cell Rev Rep - Level DAnimal StudyPubMed
Exploring the therapeutic potential of silkworm pupae extract and stromal vascular fraction in diabetic wound healing.
Animal Study on Diabetic Foot, Chronic Wound, Chronic Inflammation, published in Tissue Cell (2025) — summary generated from the PubMed abstract.
- 2025
Tissue Cell1 citations - Level BClinical TrialPubMed
Enhancing the clinical potential: Quality assessment of adipose tissue-derived Mesenchymal Stem/Stromal Cells for therapeutic use.
Clinical Trial on Neuroinflammation, published in Adv Med Sci (2025) — summary generated from the PubMed abstract.
- 2025
Adv Med Sci - Level DNarrative ReviewPubMed
Therapeutic potential of adipose derived stromal cells for major skin inflammatory diseases.
Narrative Review on Chronic Inflammation, Immune Modulation, published in Front Med (Lausanne) (2024) — summary generated from the PubMed abstract.
- 2024
Front Med (Lausanne)2 citations - Level DLaboratory StudyPubMed
Proteomic analysis and functional validation reveal distinct therapeutic capabilities related to priming of mesenchymal stromal/stem cells with IFN-γ and hypoxia: potential implications for their clinical use.
Laboratory Study, published in Front Cell Dev Biol (2024) — summary generated from the PubMed abstract.
- 2024
Front Cell Dev Biol - Level DNarrative ReviewEurope PMC
The Therapeutic Potential of Human Umbilical Cord Mesenchymal Stromal Cells Derived Exosomes for Wound Healing: Harnessing Exosomes as a Cell-free Therapy
Narrative Review on Chronic Wound, Scar, published in J Stem Cells Regen Med (2024) — summary generated from the PubMed abstract.
- 2024
J Stem Cells Regen Med7 citations - Level CProspective StudyPubMed
Targeting miR-29 mitigates skeletal senescence and bolsters therapeutic potential of mesenchymal stromal cells.
Prospective Study, published in Cell Rep Med (2024) — summary generated from the PubMed abstract.
- 2024
Cell Rep Med - Level DAnimal StudyPubMed
Human uncultured adipose-derived stromal vascular fraction shows therapeutic potential against osteoarthritis in immunodeficient rats via direct effects of transplanted M2 macrophages.
Animal Study on Osteoarthritis, Meniscus Injury, published in Stem Cell Res Ther (2024) — summary generated from the PubMed abstract.
- 2024
Stem Cell Res Ther11 citations - Level DAnimal StudyPubMed
Therapeutic Potential of Stromal Vascular Fraction in Enhancing Wound Healing: A Preclinical Study.
Animal Study on Chronic Wound, published in Aesthetic Plast Surg (2024) — summary generated from the PubMed abstract.
- 2024
Aesthetic Plast Surg2 citations - Level DNarrative ReviewEurope PMC
The roles and therapeutic potentialof mesenchymal stem/stromal cells and their extracellular vesicles in tendinopathies
Narrative Review on Tendon Injury, Chronic Inflammation, Immune Modulation, published in Front Bioeng Biotechnol (2023) — summary generated from the PubMed abstract.
- 2023
Front Bioeng Biotechnol16 citations - Level DLaboratory StudyEurope PMC
Antisense Oligonucleotides against Let-7 Enhance the Therapeutic Potential of Mesenchymal Stromal Cells
Laboratory Study, published in Int J Mol Sci (2023) — summary generated from the PubMed abstract.
- 2023
Int J Mol Sci3 citations - Level BClinical TrialEurope PMC
Different priming strategies improve distinct therapeutic capabilities of mesenchymal stromal/stem cells: Potential implications for their clinical use
Clinical Trial on Chronic Inflammation, published in World J Stem Cells (2023) — summary generated from the PubMed abstract.
- 2023
World J Stem Cells37 citations - Level BClinical TrialPubMed
Mesenchymal stromal cells loaded with Paclitaxel (PacliMES) a potential new therapeutic approach on mesothelioma.
Clinical Trial on Systemic / IV, published in Biochem Pharmacol (2023) — summary generated from the PubMed abstract.
- 2023
Biochem Pharmacol - Level DNarrative ReviewPubMed
Harnessing the therapeutic potential of mesenchymal stem/stromal cell-derived extracellular vesicles as a novel cell-free therapy for animal models of multiple sclerosis.
Narrative Review on Neuroinflammation, Immune Modulation, Autoimmune Research, published in Exp Neurol (2023) — summary generated from the PubMed abstract.
- 2023
Exp Neurol - Level DLaboratory StudyPubMed
Extracellular vesicles from hair follicle-derived mesenchymal stromal cells: isolation, characterization and therapeutic potential for chronic wound healing.
Laboratory Study on Diabetic Foot, Chronic Wound, Immune Modulation, published in Stem Cell Res Ther (2022) — summary generated from the PubMed abstract.
- 2022
Stem Cell Res Ther
In-depth reviewed studies (full Thai translation)
Evidence system- Level ARandomized Controlled Trial
Cell-based versus corticosteroid injections for knee pain in osteoarthritis: a randomized phase 3 trial
A multicentre randomized trial in 480 knee osteoarthritis patients comparing SVF, BMAC and umbilical cord MSCs against corticosteroid injection. At 12 months no cell product outperformed the steroid control.
- 2023
- United States
- n = 480
- Level AMeta-analysis
Intra-articular Injection of Autologous Adipose-Derived Stem Cells or Stromal Vascular Fractions: Are They Effective for Patients With Knee Osteoarthritis? A Systematic Review With Meta-analysis of Randomized Controlled Trials
Pooled five RCTs comparing ADSC/SVF injection with placebo or hyaluronic acid, finding significant pain and function improvement at 6 and 12 months.
- 2023
- South Korea
- Level AMeta-analysis
Rapid-acting pain relief in knee osteoarthritis: autologous-cultured adipose-derived mesenchymal stem cells outperform stromal vascular fraction: a systematic review and meta-analysis
Analysed 31 studies with 1,406 patients: cultured ADMSCs reduced pain from month 3, whereas SVF reached significance only at 12 months.
- 2024
- South Korea
- n = 1406